Direct targeting of oncohistone mutations in diffuse midline glioma
Active Project Grant Awarded Last action
- Award ID
- HT9425261E384
- Recipient
-
ST Jude Children's Research Hospital Inc. UEI JL4JHE9SDRR3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $560,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 10% complete
- Place of performance
- Memphis, TN 38105, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded ST Jude Children's Research Hospital Inc. $560,000 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support direct targeting of oncohistone mutations in diffuse midline glioma. The award funds research on novel therapeutic approaches to a pediatric brain tumor characterized by recurrent histone mutations, with performance through August 31, 2028, at the hospital's Memphis, Tennessee location. The project grant supports basic and applied biomedical research aligned with the Defense Health Agency's mission to transform health care for Service Members and the American public through innovative research, with particular relevance to advancing medical knowledge applicable to pediatric oncology and CNS malignancies.
Quick answers
Who received award HT9425261E384?
HT9425261E384 was awarded to ST Jude Children's Research Hospital Inc. by Defense Health Agency (Department of Defense) on September 1, 2026.
How much is award HT9425261E384 worth?
$560,000 has been obligated on HT9425261E384.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award